2011
DOI: 10.1016/j.bmc.2011.03.031
|View full text |Cite
|
Sign up to set email alerts
|

Development of new indole-derived neuroprotective agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(6 citation statements)
references
References 38 publications
(36 reference statements)
0
5
0
1
Order By: Relevance
“…In the scope of research program aimed at the development of new alternatives to treat neurological disorders [10,17,18]. We described in this study the synthesis of new candidates for regression of AD in experimental animal model.…”
Section: Introductionmentioning
confidence: 99%
“…In the scope of research program aimed at the development of new alternatives to treat neurological disorders [10,17,18]. We described in this study the synthesis of new candidates for regression of AD in experimental animal model.…”
Section: Introductionmentioning
confidence: 99%
“…引入四唑环片段的吲哚类化合物 78 具有较强抗 氧化和自由基清除作用, 通过抑制脂质过氧化产物含 量、增强抗氧化酶活性和诱导 GSH 的合成来抑制氧化 应激反应的发生. 四唑环和吲哚环的同时存在使其抗氧 化活性显著增强 [98] . [101] .…”
Section: Scheme 10unclassified
“…should have the highest anti-fibrinolytic efficacy. Considering oxidative stress is one of the risk factors in the development of cardiovascular diseases and indole is a free radical scavenger and able to alleviate the adverse effects of stress factors, has broad-spectrum antioxidant activity and is a potent stimulator of immune function, [21][22][23] the aminoacyl at the 2-position was focused on tryptophanyl. Herein we used a model system to evaluate the anti-fibrinolytic efficacy and to explore the action mechanism of CIPPC as a novel u-PA (urokinase-PA, UK-PA) inhibitor.…”
Section: Papermentioning
confidence: 99%